Ratings by Alliance Global Partners (James Molloy)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/8/2026 | Icannex Holdings | IXHL | New Coverage | Buy (N/A) |
2.92 (3.76) |
28.77% | Details | |
| 12/16/2025 | NanoViricides | NNVC | New Coverage | Buy (N/A) |
1.23 (1.38) |
12.2% | Details | |
| 1/30/2025 | BioCardiAa | BCDA | Upgrade | Buy (Neutral) |
2.38 (1.24) |
-47.9% | Details | |
| 1/24/2025 | CNS Pharmasceuticals Inc. | CNSP | New Coverage | Buy (N/A) |
0.10 (4.78) |
4680% | Details | |
| 1/13/2025 | Intensity Therapeutics, Inc. | INTS | New Coverage | Buy (N/A) |
2.15 (4.10) |
90.7% | Details | |
| 12/9/2024 | vTv Therapeutics | VTVT | New Coverage | Buy (N/A) |
17.92 (37.65) |
110.1% | Details | |
| 11/11/2024 | GeoVax Labs Inc. | GOVX | New Coverage | Buy (N/A) |
1.95 (1.27) |
-34.87% | Details | |
| 10/21/2024 | INmune Bio Inc. | INMB | New Coverage | Buy (N/A) |
5.11 (1.63) |
-68.1% | Details | |
| 7/17/2024 | PEDEVCO Corp | PED | New Coverage | Buy (N/A) |
0.97 (13.46) |
1287.63% | Details | |
| 7/17/2024 | Pyxis Tankers | PXS | New Coverage | Buy (N/A) |
4.98 (4.16) |
-16.47% | Details | |
| 7/17/2024 | IGC Pharma, Inc. | IGC | New Coverage | Buy (N/A) |
0.45 (0.27) |
-40% | Details | |
| 6/25/2024 | Alimera Sciences | ALIM | Downgrade | Neutral (Buy) |
5.54 (5.54) |
0% | Details | |
| 6/18/2024 | Chromocell Therapeutics Corp. | CHRO | New Coverage | Buy (N/A) |
1.26 (1.35) |
7.14% | Details | |
| 5/2/2024 | Aspira Women’s Health | AWH | New Coverage | Buy (N/A) |
3.22 (0.08) |
-97.52% | Details | |
| 10/30/2023 | Alimera Sciences | ALIM | Upgrade | Buy (Neutral) |
3.16 (5.54) |
75.32% | Details | |
| 10/9/2023 | Aptevo Therapeutics | APVO | New Coverage | Buy (N/A) |
0.33 (4.44) |
1245.45% | Details | |
| 10/2/2023 | AcelRx Pharmaceuticals | ACRX | New Coverage | Buy (N/A) |
0.58 (0.86) |
48.28% | Details | |
| 9/25/2023 | Vaccitech | VACC | New Coverage | Buy (N/A) |
1.68 (5.00) |
197.62% | Details | |
| 7/17/2023 | NeuroSense Therapeutics Ltd. | NRSN | New Coverage | Buy (N/A) |
1.36 (0.72) |
-47.06% | Details | |
| 6/12/2023 | Alimera Sciences | ALIM | Upgrade | Buy (Neutral) |
2.50 (5.54) |
121.6% | Details | |
| 3/6/2023 | Athersys | ATHX | New Coverage | Buy (N/A) |
1.53 (0.10) |
-93.46% | Details | |
| 1/23/2023 | Hepion Pharma | HEPA | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2022 | Alimera Sciences | ALIM | Downgrade | Neutral (Buy) |
4.25 (5.54) |
30.35% | Details | |
| 6/1/2022 | Enveric Biosciences | ENVB | New Coverage | Buy (N/A) |
0.20 (1.38) |
590% | Details | |
| 3/24/2022 | Ampio Pharmaceuticals | AMPE | New Coverage | Buy (N/A) |
0.43 (0.18) |
-58.14% | Details | |
| 3/16/2022 | Entasis Therapeutics | ETTX | Downgrade | Neutral (Buy) |
1.86 (2.19) |
17.74% | Details | |
| 11/9/2021 | Oramed Pharma | ORMP | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2021 | Achieve Life Sciences | ACHV | New Coverage | Buy (N/A) |
8.45 (6.53) |
-22.72% | Details | |
| 4/5/2021 | Ocuphire | OCUP | New Coverage | Buy (N/A) |
6.38 (1.17) |
-81.66% | Details | |
| 11/16/2020 | Entasis Therapeutics | ETTX | New Coverage | Buy (N/A) |
1.72 (2.19) |
27.33% | Details | |
| 8/25/2020 | Qualigen Therapeutics | QLGN | Upgrade | Buy (Neutral) |
4.62 (3.21) |
-30.52% | Details | |
| 8/10/2020 | PolyPid Ltd. | PYPD | New Coverage | Buy (N/A) |
14.21 (5.08) |
-64.25% | Details | |
| 5/5/2020 | Stemline Therapeutics | STML | Downgrade | Neutral (Buy) |
4.75 (11.83) |
149.05% | Details | |
| 4/22/2020 | Genprex | GNPX | New Coverage | Buy (N/A) |
1.99 (0.52) |
-73.87% | Details | |
| 2/28/2020 | Alimera Sciences | ALIM | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2019 | AIM ImmunoTech | AIM | New Coverage | Buy (N/A) |
0.49 (0.28) |
-42.86% | Details | |
| 11/26/2019 | Tonix Pharma | TNXP | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2019 | Stemline Therapeutics | STML | New Coverage | Buy (N/A) |
10.61 (4.75) |
-55.23% | Details | |
| 11/14/2019 | Cocrystal Pharma, Inc. | COCP | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2019 | Heat Biologics | HTBX | Maintain | Buy (N/A) |
|
Details |
